Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Global X Genomics & Biotechnology ETF (GNOM)

Global X Genomics & Biotechnology ETF (GNOM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Global X Mgt
  • Assets Under Management 287,795,200
  • Shares Outstanding, K 12,320
  • 60-Month Beta 1.03
Trade GNOM with:
  • Price/Earnings ttm -24.19
  • Annual Dividend & Yield 0.03 (0.14%)
  • Most Recent Dividend 0.032 on 12/30/20
  • Management Fee 0.50%
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 29.30%
  • Historical Volatility 26.45%
  • IV Percentile 30%
  • IV Rank 47.65%
  • IV High 59.66% on 09/21/21
  • IV Low 1.67% on 05/18/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 10

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.96 +1.13%
on 09/27/21
25.05 -7.31%
on 09/02/21
-0.84 (-3.49%)
since 08/27/21
3-Month
21.68 +7.10%
on 07/27/21
25.68 -9.58%
on 07/02/21
-0.75 (-3.13%)
since 06/25/21
52-Week
17.70 +31.15%
on 09/28/20
28.45 -18.38%
on 02/10/21
+5.46 (+30.74%)
since 09/25/20

Most Recent Stories

More News
Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan

The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.

IHE : 185.52 (-0.51%)
XHE : 128.92 (-0.77%)
GNOM : 23.22 (-0.68%)
HELX : 54.74 (-2.89%)
GERM : 42.56 (-1.80%)
VIRS : 33.33 (-1.25%)
How Are Genomics ETFs Responding to Q2 Earnings?

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

BEAM : 94.84 (+0.18%)
EDIT : 57.84 (-1.48%)
PBE : 76.46 (-1.34%)
NTLA : 147.58 (-1.05%)
CRSP : 117.26 (+0.71%)
ARKG : 78.25 (-0.51%)
GNOM : 23.22 (-0.68%)
IDNA : 52.89 (-1.14%)
Sorrento Mexico and the National Institute of Genomic Medicine (INMEGEN) of Mexico Government Execute Memorandum of Understanding (MOU) for Rapid Clinical Development of COVID-19 Diagnostics, Therapeutics and Multivalent mRNA-Based Vaccines Against SARS-CoV-2 and Its Variants of Concerns

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that its subsidiary company, Sorrento Therapeutics Mexico ("Sorrento Mexico"), has entered into an MOU agreement with the National...

GNOM : 23.22 (-0.68%)
SRNE : 8.14 (+3.96%)
A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

BEAM : 94.84 (+0.18%)
EDIT : 57.84 (-1.48%)
PBE : 76.46 (-1.34%)
NTLA : 147.58 (-1.05%)
CRSP : 117.26 (+0.71%)
ARKG : 78.25 (-0.51%)
GNOM : 23.22 (-0.68%)
IDNA : 52.89 (-1.14%)
Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

REGN : 619.07 (-3.10%)
BEAM : 94.84 (+0.18%)
EDIT : 57.84 (-1.48%)
NTLA : 147.58 (-1.05%)
CRSP : 117.26 (+0.71%)
ARKG : 78.25 (-0.51%)
GNOM : 23.22 (-0.68%)
IDNA : 52.89 (-1.14%)
4 ETF Areas Surged Last Week

These four ETF areas were winners last week.

AMLP : 33.93 (+3.29%)
AMZA : 26.71 (+3.81%)
BTEC : 56.53 (+0.22%)
BDRY : 34.35 (+5.76%)
GNOM : 23.22 (-0.68%)
BUG : 31.56 (-1.62%)
Top-Performing Biotech ETFs of Last Week

Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

BIIB : 286.62 (-1.74%)
FBT : 170.67 (-1.29%)
SBIO : 47.60 (+2.28%)
BTEC : 56.53 (+0.22%)
ARKG : 78.25 (-0.51%)
GNOM : 23.22 (-0.68%)
ORPH : 4.42 (+0.45%)
CLOV : 8.10 (+4.79%)
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval

The approval for Biogen's Alzheimer's disease treatment has spread strong optimism, with many investors pulling in capital to this high growth and high beta sector.

BIIB : 286.62 (-1.74%)
LLY : 226.40 (-2.28%)
XBI : 131.91 (+1.18%)
BBC : 48.35 (+1.60%)
SBIO : 47.60 (+2.28%)
PBE : 76.46 (-1.34%)
GNOM : 23.22 (-0.68%)
Top-Performing Biotech ETFs Amid the COVID-19 Crisis

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

XBI : 131.91 (+1.18%)
BTEC : 56.53 (+0.22%)
ARKG : 78.25 (-0.51%)
GNOM : 23.22 (-0.68%)
IDNA : 52.89 (-1.14%)
ETFs in Focus on Bayer's Bet on Gene Therapy

Bayer has made a big bet on gene therapy by announcing the acquisition of U.S. biotech firm Asklepios BioPharmaceutical for as much as $4 billion.

PBE : 76.46 (-1.34%)
ARKG : 78.25 (-0.51%)
GNOM : 23.22 (-0.68%)
IDNA : 52.89 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The Global X Genomics and Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.

See More

Key Turning Points

3rd Resistance Point 23.82
2nd Resistance Point 23.59
1st Resistance Point 23.41
Last Price 23.22
1st Support Level 23.00
2nd Support Level 22.77
3rd Support Level 22.59

See More

52-Week High 28.45
Fibonacci 61.8% 24.35
Last Price 23.22
Fibonacci 50% 23.08
Fibonacci 38.2% 21.81
52-Week Low 17.70

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar